10 Reasons Drug Prices Are Too High and What You Can Do About It!

Reasons Drug Prices Are Too High
Reasons Drug Prices Are Too High

The skyrocketing cost of prescription drugs is a critical concern for many people, particularly those living with chronic illnesses or who require frequent medication. High drug prices can create significant financial burdens for individuals and families, leading to tough choices between essential medications and other basic necessities. In this article, we will explore the top ten reasons why drug prices are so high and discuss possible solutions that individuals, communities, and policymakers can implement to address this pressing issue.

1: Patent Protection and Monopolies

One of the main factors driving high drug prices is the monopoly granted to pharmaceutical companies through patent protections. These patents give companies exclusive rights to sell a drug for a specific period, often 20 years, preventing competition and enabling them to set prices without constraints.

What you can do: Advocate for patent reform that encourages competition and lowers drug prices, such as shorter patent terms or the implementation of compulsory licensing for essential medicines.

2: High Research and Development Costs

Pharmaceutical companies argue that the high costs of researching and developing new drugs justify the high prices. Indeed, the process of bringing a drug to market can take over a decade and cost billions of dollars. However, some argue that these costs are often inflated or that companies may spend more on marketing than R&D.

What you can do: Support public funding for scientific research to reduce the reliance on private pharmaceutical companies and their need to recoup R&D expenses through high drug prices.

3: Price Gouging

Price gouging occurs when companies drastically increase the price of a drug, often without justification. This practice can lead to enormous profits for the company but leaves patients struggling to afford their medications.

What you can do: Support legislation that limits the ability of pharmaceutical companies to raise drug prices without justification, and report instances of suspected price gouging to consumer protection agencies.

4: Lack of Price Regulation

Unlike many other countries, the United States does not have a centralized system for negotiating drug prices, allowing pharmaceutical companies to set prices at their discretion. This lack of price regulation contributes to higher drug costs.

What you can do: Advocate for the establishment of a national drug price negotiation system to help control costs and ensure that patients have access to affordable medications.

5: The Role of Pharmacy Benefit Managers

Pharmacy benefit managers (PBMs) are middlemen who negotiate drug prices between manufacturers and insurers. While they were initially created to lower drug costs, some argue that PBMs contribute to high prices through complex and opaque pricing practices.

What you can do: Support transparency initiatives that require PBMs to disclose their pricing and rebate practices, allowing for better scrutiny of their role in the drug pricing process.

6: High Costs of Marketing and Advertising

Pharmaceutical companies spend billions of dollars each year on marketing and advertising, with some estimates suggesting that they spend more on these activities than on research and development. These costs are then passed on to consumers in the form of higher drug prices.

What you can do: Encourage the adoption of policies that limit the amount of money that pharmaceutical companies can spend on marketing and advertising, or support legislation that requires companies to disclose their marketing and R&D expenditures.

7: Prescription Drug Importation Restrictions

The United States has stringent restrictions on the importation of prescription drugs, making it difficult for consumers to access more affordable medications from other countries. These restrictions limit competition and contribute to higher prices.

What you can do: Advocate for policies that allow for the safe and legal importation of prescription drugs from countries with lower prices, expanding access to more affordable medications.

8: Orphan Drug Pricing

Orphan drugs are medications developed to treat rare diseases, which often affect a small number of patients. Because of the limited market for these drugs, pharmaceutical companies often charge very

high prices to recoup their investments. However, this can make it nearly impossible for patients with rare diseases to afford the life-saving treatments they need.

What you can do: Support policies that incentivize the development of orphan drugs while also ensuring that they remain affordable for patients, such as providing tax credits or subsidies for research and development.

9: Limited Competition and Price-Fixing

In some cases, a lack of competition in the pharmaceutical market can lead to artificially high drug prices. This can occur when only one or a few companies produce a specific drug, giving them significant pricing power. Additionally, price-fixing, where companies collude to set artificially high prices, can also contribute to inflated drug costs.

What you can do: Encourage antitrust enforcement to prevent anti-competitive practices in the pharmaceutical industry, and support legislation that promotes competition and price transparency.

10: Cost-Shifting from Uninsured Patients

When uninsured patients are unable to pay for their medications, the costs are often shifted to those with insurance in the form of higher drug prices. This cost-shifting can contribute to the overall increase in drug prices and make it more challenging for insured patients to afford their medications.

What you can do: Advocate for policies that expand access to affordable healthcare and insurance coverage, reducing the need for cost-shifting and lowering drug prices for all.


The high cost of prescription drugs is a complex issue with numerous contributing factors. By understanding these factors and advocating for policies and practices that address them, individuals and communities can play a role in helping to lower drug prices and ensure that all patients have access to the medications they need. From patent reform and price negotiation to increased transparency and competition, there are many potential solutions that can be implemented to address this pressing issue. Together, we can work towards a future where essential medications are accessible and affordable for everyone.

Leave a Comment